Zevra Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Zevra Therapeutics, Inc. (ZVRA) had Deferred Tax Assets, Operating Loss Carryforwards of $63.26 million as of 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-09
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $63.26M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $100.55M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $90.74M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $66.37M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $63.26M 10-K · filed 2026-03-09 |
| 2024-12-31 | $100.55M 10-K · filed 2026-03-09 |
| 2023-12-31 | $90.74M 10-K · filed 2025-03-12 |
| 2022-12-31 | $66.37M 10-K · filed 2024-04-01 |
| 2021-12-31 | $60.98M 10-K · filed 2023-03-07 |
| 2020-12-31 | $59.05M 10-K · filed 2022-03-31 |
| 2019-12-31 | $56.83M 10-K · filed 2021-03-12 |
| 2018-12-31 | $51.27M 10-K · filed 2020-02-28 |
| 2017-12-31 | $37.03M 10-K · filed 2019-03-01 |
| 2016-12-31 | $44.98M 10-K · filed 2018-03-30 |
| 2015-12-31 | $26.62M 10-K · filed 2018-03-30 |
| 2014-12-31 | $16.39M 10-K · filed 2017-03-10 |
| 2013-12-31 | $9.61M 10-K · filed 2016-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |